Cite
HARVARD Citation
Pacheco-Barcia, V. et al. (n.d.). P-164Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival. Annals of oncology. p. . [Online].